We are live on ! Find out more
ORIA

Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA

Delisted

ORIA was delisted on the 28th of April, 2023.

Back to rankings

48 hedge funds and large institutions have $130M invested in Orion Biotech Opportunities Corp. Class A Ordinary Share in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

20% more funds holding

Funds holding: 40 → 48 (+8)

4% more capital invested

Capital invested by funds: $124M → $130M (+$5.54M)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

Holders
48
Holders Change
+8
Holders Change %
+20%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
7
Reduced
8
Closed
2
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
HSBC Holdings
HSBC Holdings
United Kingdom
+$6.43M
2
UOC
UBS O'Connor
Illinois
+$2.55M
3
CF
Cantor Fitzgerald
New York
+$1.95M
4
TCA
Taconic Capital Advisors
New York
+$1.9M
5
FTCM
First Trust Capital Management
Illinois
+$1.71M

Top Sellers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
-$6.43M
2
ACA
Arena Capital Advisors
California
-$2.47M
3
FTCM
Fir Tree Capital Management
New York
-$485K
4
FLC
Fifth Lane Capital
Texas
-$326K
5
EAM
Exos Asset Management
New York
-$92.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
26
Rivernorth Capital Management
Florida
$1.68M – – –
PMAM
27
Picton Mahoney Asset Management
Ontario, Canada
$1.46M – – –
DCM
28
DG Capital Management
New York
$1.24M – – –
CCM
29
Context Capital Management
California
$1.03M – – –
CH
30
CVI Holdings
Delaware
$990K – – –
DCM
31
Dupont Capital Management
Delaware
$974K – – –
AFM
32
Anson Funds Management
Texas
$730K – – –
WA
33
Whitebox Advisors
Minnesota
$730K – – –
GCL
34
Glazer Capital LLC
New York
$656K +$383K +39,184 +139%
BCM
35
Basso Capital Management
Connecticut
$488K +$1.12K +115 +0.2%
LOAMU
36
Lombard Odier Asset Management (USA)
New York
$487K -$107 -11 -0%
SSA
37
Schonfeld Strategic Advisors
New York
$486K +$487K +49,881 New
COPPSERS
38
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$486K +$488K +49,945 New
EAM
39
Exos Asset Management
New York
$422K -$92.7K -9,496 -18%
LA
40
Linden Advisors
New York
$407K -$6.43M -658,186 -94%
Bank of Nova Scotia
41
Bank of Nova Scotia
Ontario, Canada
$390K – – –
PAMP
42
Polar Asset Management Partners
Ontario, Canada
$262K +$263K +26,900 New
HF
43
HRT Financial
New York
$196K +$1.41K +144 +0.7%
CC
44
Centiva Capital
New York
$106K +$106K +10,840 New
WAM
45
Wolverine Asset Management
Illinois
$97K +$75.4K +7,717 +338%
SCM
46
Segantii Capital Management
Hong Kong
$1.46K – – –
MF
47
Magnetar Financial
Illinois
$221 +$222K +22,727 New
SCC
48
Spring Creek Capital
Kansas
– -$7.81M -800,000 Closed
FLC
49
Fifth Lane Capital
Texas
– -$326K -33,500 Closed
1
2

ORIA Hedge Fund Activity: Q2 2022 in Review

48 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) for Q2 2022, worth a combined $130M — up 4.5% from $124M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ORIA positions and 2 closed out — a net gain of 8 holders — while 7 added to existing stakes and 8 trimmed.

The largest buyer was HSBC Holdings, opening a new position worth an estimated $6.43M. The largest seller was Linden Advisors, cutting an estimated $6.43M.

  • 48 institutional investors held Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) as of Q2 2022, up from 40 in Q1 2022.
  • Funds reported $130M of Orion Biotech Opportunities Corp. Class A Ordinary Share stock for Q2 2022, up 4.5% quarter-over-quarter.
  • 10 funds opened new Orion Biotech Opportunities Corp. Class A Ordinary Share positions in Q2 2022 and 2 closed out, a net change of +8 holders.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share buyer in Q2 2022 was HSBC Holdings, an estimated $6.43M added.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share seller in Q2 2022 was Linden Advisors, an estimated $6.43M sold.

Based on aggregated 13F filings for Q2 2022.